Form 4: Macrogenics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Ezio Bonvini, Sr VP, Research & CSO of Macrogenics Inc, reported multiple transactions in common stock on October 6, 2026.
Summary
- Option exercise/conversion: acquired 8,000 Common Stock at $2.60 ($20,800) on October 6, 2026; holds 193,799 after (Direct).
- Option exercise/conversion: disposed of 8,000 Employee Stock Option (right to buy) at $2.60 ($20,800) on October 6, 2026; holds 80,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ezio Bonvini — Officer (Sr VP, Research & CSO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-06 | Option exercise/conversion | Common Stock | 8,000 | $3 | $20.8K | 193,799 |
| 2026-10-06 | Option exercise/conversion | Employee Stock Option (right to buy) | 8,000 | $3 | $20.8K | 80,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-06 | Option exercise/conversion (8,000 shares) |
| 2026-10-06 | Option exercise/conversion (8,000 shares) |
Keywords
insider transaction, Form 4, MGNX, MACROGENICS INC, neutral, Ezio Bonvini
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.